Founding Partner
More than 140,000 bottles of a widely prescribed cholesterol medication, atorvastatin calcium, the generic version of Lipitor, have been pulled from the U.S. market. According to the Food and Drug Administration (FDA), the recall affects multiple dosages and lot numbers and was issued after the medication failed dissolution testing, which means it may not break down properly in the body.
Atorvastatin is used to lower LDL (bad) cholesterol and reduce the risk of serious cardiovascular events like heart attacks and strokes. When a medication does not dissolve correctly, its effectiveness is compromised. For patients relying on this drug to manage their cholesterol and prevent life-threatening events, the consequences can be significant.
This national recall, issued by Ascend Laboratories on September 19, 2025, affects thousands of consumers who may have no idea their medication has been recalled. With no press release from the company and limited public outreach, many people could still be using defective tablets without knowing the risks. This situation may give rise to legal claims from individuals harmed due to reduced effectiveness or undisclosed side effects.
Atorvastatin calcium is a type of medication known as a statin. Statins are one of the most commonly prescribed drug classes in the United States, helping millions of people manage high cholesterol and prevent heart disease. Atorvastatin works by reducing the amount of cholesterol made by the liver and improving the body’s ability to remove cholesterol from the bloodstream.
Doctors prescribe atorvastatin to:
Because of its broad benefits, this drug is used in primary and secondary prevention. Patients rely on consistent dosing and absorption to keep cholesterol levels stable. When tablets do not dissolve as expected, they can lead to insufficient dosage, leaving patients vulnerable to the very health events the drug is supposed to prevent.
The FDA classified the recall as a Class II recall, which means use of the drug may lead to temporary or medically reversible health effects, with a low but existing risk of serious harm. Although this level is not the most urgent (Class I), it still presents real concerns—especially in a medication used to prevent heart disease.
Ascend Laboratories initiated the recall because certain lots of atorvastatin failed dissolution specifications. This refers to the drug’s ability to dissolve in the body and become bioavailable, or usable by the body. If a pill does not dissolve properly, it may:
According to the FDA’s enforcement report, over 141,984 bottles have been affected, including several dosages and expiration dates. The risk increases with continued use over time, particularly for patients who assume their cholesterol is under control based on a faulty medication.
Atorvastatin calcium tablets involved in the recall were manufactured by Ascend Laboratories, LLC, based in New Jersey. While the company did not issue a public-facing press release, the FDA published the list of recalled lot numbers and expiration dates on its website.
The recall includes multiple bottle sizes and strengths, such as:
These bottles may have been dispensed through retail pharmacies, mail-order services, or hospital networks. Patients should carefully check the label on their pill bottles and compare it to the recall list posted by the FDA. Even without visible damage, the tablets could still be ineffective.
If you suspect your medication may be part of the recall, the following steps are recommended:
For those who have already taken defective tablets for a period of time, a healthcare provider may recommend blood tests to determine whether cholesterol levels have been adversely affected.
The reason this recall is concerning is that patients taking defective atorvastatin may unknowingly face increased risks, including:
Delayed effects may go unnoticed until a serious cardiac event occurs. For individuals who have experienced worsening symptoms or unexpected medical episodes while on recalled atorvastatin, there could be a direct link between the defective drug and their injuries.
Patients who suffer harm due to defective medication have a right to pursue compensation through product liability claims. These legal claims are designed to hold pharmaceutical companies accountable for manufacturing and distributing unsafe drugs.
Legal grounds may include:
Victims may be eligible to recover compensation for:
What is atorvastatin used for?
Atorvastatin is a statin medication prescribed to lower bad cholesterol, raise good cholesterol, and reduce the risk of heart attacks, strokes, and other cardiovascular problems.
Why was atorvastatin recalled?
The FDA recall was issued after the drug failed laboratory tests that measure how well the tablet dissolves. Poor dissolution can reduce the medication’s effectiveness, placing patients at risk.
How can I find out if my atorvastatin is part of the recall?
Check your prescription bottle for the manufacturer name (Ascend Laboratories), dosage, and lot number. Compare that information with the FDA’s published recall list. If you’re unsure, contact your pharmacy or physician.
What are the risks of taking defective atorvastatin?
Patients may experience ineffective cholesterol control, leading to higher risks of heart attack, stroke, and other complications. Continued use of defective tablets could have serious or even fatal consequences.
Can I sue if I was harmed by recalled atorvastatin?
Yes. If you suffered harm due to defective atorvastatin—such as a heart attack or hospitalization—you may be eligible for a product liability claim.
What kind of compensation can I receive?
Legal compensation may include hospital bills, long-term medical care, lost wages, pain and suffering, and other damages related to your health decline.
How long do I have to file a lawsuit?
Time limits vary by state, but most product liability lawsuits must be filed within a specific window after the injury is discovered. You should speak with a personal injury law firm immediately to protect your rights.
If you or someone you care about experienced serious health complications while taking recalled atorvastatin, you may be entitled to financial compensation. Parker Waichman LLP is a national personal injury law firm with a long track record of pursuing pharmaceutical liability claims. We are currently investigating cases related to the atorvastatin recall and helping victims nationwide understand their rights.
Call 1-800-YOUR-LAWYER (1-800-968-7529) today for a free consultation. Our legal team is standing by to evaluate your case and explain your options. You do not pay anything unless we win your case. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.
Parker Waichman LLP
Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
Parker Waichman LLP
27299 Riverview Center Boulevard, Suite 108
Bonita Springs, FL 34134
We handle mass torts cases nationwide. Please contact our office to learn more.